171 related articles for article (PubMed ID: 37993904)
21. Aberrant H19 Expression Disrupts Ovarian Cyp17 and Testosterone Production and Is Associated with Polycystic Ovary Syndrome in Women.
Chen Z; Liu L; Xi X; Burn M; Karakaya C; Kallen AN
Reprod Sci; 2022 Apr; 29(4):1357-1367. PubMed ID: 34655046
[TBL] [Abstract][Full Text] [Related]
22. Genetic variation in PRL and PRLR, and relationships with serum prolactin levels and breast cancer risk: results from a population-based case-control study in Poland.
Nyante SJ; Faupel-Badger JM; Sherman ME; Pfeiffer RM; Gaudet MM; Falk RT; Andaya AA; Lissowska J; Brinton LA; Peplonska B; Vonderhaar BK; Chanock S; Garcia-Closas M; Figueroa JD
Breast Cancer Res; 2011 Apr; 13(2):R42. PubMed ID: 21470416
[TBL] [Abstract][Full Text] [Related]
23. A genetic risk score is associated with polycystic ovary syndrome-related traits.
Lee H; Oh JY; Sung YA; Chung HW
Hum Reprod; 2016 Jan; 31(1):209-15. PubMed ID: 26573528
[TBL] [Abstract][Full Text] [Related]
24. Clinical characteristics, metabolic features, and phenotype of Chinese women with polycystic ovary syndrome: a large-scale case-control study.
Zhang HY; Guo CX; Zhu FF; Qu PP; Lin WJ; Xiong J
Arch Gynecol Obstet; 2013 Mar; 287(3):525-31. PubMed ID: 23108387
[TBL] [Abstract][Full Text] [Related]
25. Polycystic ovarian syndrome.
Trikudanathan S
Med Clin North Am; 2015 Jan; 99(1):221-35. PubMed ID: 25456652
[TBL] [Abstract][Full Text] [Related]
26. Catechol-O-methyltransferase (COMT) single nucleotide polymorphisms and haplotypes are not major risk factors for polycystic ovary syndrome.
Hill LD; Ewens KG; Maher BS; York TP; Legro RS; Dunaif A; Strauss JF
Mol Cell Endocrinol; 2012 Mar; 350(1):72-7. PubMed ID: 22178088
[TBL] [Abstract][Full Text] [Related]
27. Modulation of steroidogenesis by vitamin D3 in granulosa cells of the mouse model of polycystic ovarian syndrome.
Bakhshalizadeh S; Amidi F; Alleyassin A; Soleimani M; Shirazi R; Shabani Nashtaei M
Syst Biol Reprod Med; 2017 Jun; 63(3):150-161. PubMed ID: 28345956
[TBL] [Abstract][Full Text] [Related]
28. Polycystic ovary syndrome is not associated with genetic variants that mark risk of type 2 diabetes.
Saxena R; Welt CK
Acta Diabetol; 2013 Jun; 50(3):451-7. PubMed ID: 22389004
[TBL] [Abstract][Full Text] [Related]
29. Polycystic ovary morphology is associated with insulin resistance in women with polycystic ovary syndrome.
Hong SH; Sung YA; Hong YS; Jeong K; Chung H; Lee H
Clin Endocrinol (Oxf); 2017 Oct; 87(4):375-380. PubMed ID: 28543550
[TBL] [Abstract][Full Text] [Related]
30. Ovarian functions and polycystic ovary syndrome in adult women with type 1 diabetes mellitus in a Turkish population.
Urhan E; Elbuken G; Hacioglu A; Karaca Z; Unluhizarci K; Kelestimur F
J Endocrinol Invest; 2023 Mar; 46(3):609-616. PubMed ID: 36308639
[TBL] [Abstract][Full Text] [Related]
31. Angiotensin II type 2 receptor stimulation improves fatty acid ovarian uptake and hyperandrogenemia in an obese rat model of polycystic ovary syndrome.
Leblanc S; Battista MC; Noll C; Hallberg A; Gallo-Payet N; Carpentier AC; Vine DF; Baillargeon JP
Endocrinology; 2014 Sep; 155(9):3684-93. PubMed ID: 24971613
[TBL] [Abstract][Full Text] [Related]
32. Addressing the role of 11β-hydroxysteroid dehydrogenase type 1 in the development of polycystic ovary syndrome and the putative therapeutic effects of its selective inhibition in a preclinical model.
Li X; Hu S; Zhu Q; Yao G; Yao J; Li J; Wang Y; Ding Y; Qi J; Xu R; Zhao H; Zhu Z; Du Y; Sun K; Sun Y
Metabolism; 2021 Jun; 119():154749. PubMed ID: 33722534
[TBL] [Abstract][Full Text] [Related]
33. Pre-polycystic ovary syndrome and polymenorrhoea as new facets of polycystic ovary syndrome (PCOS): Evidences from a single centre data set.
Ganie MA; Rashid A; Baba MS; Zargar MA; Wani IA; Nisar S; Wani IA; Douhath S; Sriwastawa M; Geer MI; Asrar MM; Kutum R; Hassan S; Khan S; Rafi W; Bhat DA; Showkat W; Sahar T; Choh NA; Khurshid R; Mudassar S; Shah ZA; Shabir I; Sofi SA; Gupta N; Hafeez I; Sreenivas V
Clin Endocrinol (Oxf); 2023 Dec; 99(6):566-578. PubMed ID: 37656656
[TBL] [Abstract][Full Text] [Related]
34. Investigation of common risk factors between polycystic ovary syndrome and Alzheimer's disease: a narrative review.
Sarahian N; Sarvazad H; Sajadi E; Rahnejat N; Eskandari Roozbahani N
Reprod Health; 2021 Jul; 18(1):156. PubMed ID: 34311759
[TBL] [Abstract][Full Text] [Related]
35. Characterization of multiple first exons in murine prolactin receptor gene and the effect of prolactin on their expression in the choroid plexus.
Tabata H; Kobayashi M; Ikeda JH; Nakao N; Saito TR; Tanaka M
J Mol Endocrinol; 2012 Apr; 48(2):169-76. PubMed ID: 22294444
[TBL] [Abstract][Full Text] [Related]
36. [Life-cycle management of polycystic ovary syndrome].
Xu Y
Zhonghua Yi Xue Za Zhi; 2023 Apr; 103(14):1011-1015. PubMed ID: 37032149
[TBL] [Abstract][Full Text] [Related]
37. Clinico-Metabolic Profile in Lean Versus Obese Polycystic Ovarian Syndrome Women.
Makhija N; Tayade S; Toshniwal S; Tilva H
Cureus; 2023 Apr; 15(4):e37809. PubMed ID: 37214034
[TBL] [Abstract][Full Text] [Related]
38. Impact of the newly recommended antral follicle count cutoff for polycystic ovary in adult women with polycystic ovary syndrome.
Kim JJ; Hwang KR; Chae SJ; Yoon SH; Choi YM
Hum Reprod; 2020 Mar; 35(3):652-659. PubMed ID: 32211797
[TBL] [Abstract][Full Text] [Related]
39. Polycystic ovaries - beyond menopause.
Shah D; Bansal S
Climacteric; 2014 Apr; 17(2):109-15. PubMed ID: 23895379
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of socio-demographic and clinical characteristics of PCOS patients attending a tertiary care institute in Colombo.
Ranathunga I; Athukorala TG; Sumanatilleke MR; Somasundaram NP
BMC Endocr Disord; 2022 Nov; 22(1):289. PubMed ID: 36411444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
